XML 31 R19.htm IDEA: XBRL DOCUMENT v3.22.0.1
Note 13 - Income Taxes
12 Months Ended
Nov. 30, 2021
Notes to Financial Statements  
Income Tax Disclosure [Text Block]

(13)

Income Taxes

 

Total income tax expense (benefit) for the 2021 and 2020 fiscal years consists of the following:

 

  

November 30, 2021

  

November 30, 2020

 

Current expense (benefit)

 $8,459  $25,168 

Deferred expense (benefit)

  45,800   (881,638)

Total income tax expense (benefit)

 $54,259  $(856,470)

 

The reconciliation of the statutory Federal income tax rate is as follows:

 

  

November 30, 2021

  

November 30, 2020

 

Statutory federal income tax rate

  21.0%  21.0%

PPP Loan Forgiveness

  -   8.8 

Permanent Differences and Other

  (0.7)  (0.9)
   20.3%  28.9%

 

Tax effects of temporary differences that give rise to significant portions of the deferred tax assets (liabilities) on November 30, 2021 and 2020 are presented as approximate amounts below:

 

  

November 30

 
  

2021

  

2020

 

Current deferred tax assets (liabilities):

        

Accrued expenses

 $82,000  $161,000 

Inventory capitalization

  122,000   71,000 

NOL and tax credit carryforward

  1,846,000   1,695,000 

Asset reserves

  613,000   796,000 

Total current deferred tax assets

 $2,663,000  $2,723,000 

Non-current deferred tax assets

        

Property, plant, and equipment

 $(41,000) $(55,000)

Total non-current deferred tax assets (liabilities)

 $(41,000) $(55,000)

Net deferred taxes

 $2,622,000  $2,668,000 

 

In assessing the realizability of deferred tax assets, management considers whether it is more likely than not that some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company’s has net operating losses amounting to approximately $4,496,000 and tax credit carryforward amounting to approximately $109,000 for its U.S. operations that will expire on November 30, 2036, 2037, 2038, 2039 and 2040. The Company has another $4,507,000 of net operating losses that can be carried forward indefinitely. Management believes that the Company will be able to utilize the U.S. net operating losses and credits before their expiration.